Hormone resistance in breast cancer linked to DNA 'rewiring'

byGarvan Institute of Medical ResearchCredit: CC0 Public DomainEpigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatm

Updated on: December 20,2023

Hormone resistance in breast cancer linked to DNA 'rewiring'

byGarvan Institute of Medical ResearchCredit: CC0 Public DomainEpigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatm

Updated on:December 20,2023

Druggable targets found for treating rare, deadly nerve cancer MPNST

byCincinnati Children's Hospital Medical CenterTumor cell–state trajectories from NF to MPNST inferred by Slingshot. Arrows, transformation direction. Credit: Cincinnati Children's and S

Updated on: December 22,2023

Druggable targets found for treating rare, deadly nerve cancer MPNST

byCincinnati Children's Hospital Medical CenterTumor cell–state trajectories from NF to MPNST inferred by Slingshot. Arrows, transformation direction. Credit: Cincinnati Children's and S

Updated on:December 22,2023

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according

Updated on: December 19,2023

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according

Updated on:December 19,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on: December 21,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on:December 21,2023

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of

Updated on: December 19,2023

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of

Updated on:December 19,2023

Scan based on lizard saliva detects rare tumor

by Jared Sagoff,Radboud UniversityThis is a cross-sectional view of the torso. The gray areas show the anatomy based on the CT scan, while the colored sections represent the radioactive signal m

Updated on: October 31,2024

Scan based on lizard saliva detects rare tumor

by Jared Sagoff,Radboud UniversityThis is a cross-sectional view of the torso. The gray areas show the anatomy based on the CT scan, while the colored sections represent the radioactive signal m

Updated on:October 31,2024

Symptom self-monitoring for childhood cancer survivors—what are oncologists' views?

byKing's College LondonCredit: Unsplash/CC0 Public DomainA new international survey, led by the Stanford University Department of Anesthesiology, Perioperative, and Pain Medicine, and the In

Updated on: December 21,2023

Symptom self-monitoring for childhood cancer survivors—what are oncologists' views?

byKing's College LondonCredit: Unsplash/CC0 Public DomainA new international survey, led by the Stanford University Department of Anesthesiology, Perioperative, and Pain Medicine, and the In

Updated on:December 21,2023

Hair relaxers have been linked to cancer among Black women, litigation says. 'Nobody cares except us'

by Darcel Rockett, Chicago TribuneCredit: Unsplash/CC0 Public DomainLaTonya Shuler, 50, of Indianapolis, had planned to have children. But at age 32, she was diagnosed with uterine cancer. After six w

Updated on: January 04,2024

Hair relaxers have been linked to cancer among Black women, litigation says. 'Nobody cares except us'

by Darcel Rockett, Chicago TribuneCredit: Unsplash/CC0 Public DomainLaTonya Shuler, 50, of Indianapolis, had planned to have children. But at age 32, she was diagnosed with uterine cancer. After six w

Updated on:January 04,2024

AI in histopathology image analysis for cancer precision medicine

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainIn recent years, there have been rapid advancements in the field of computational pathology, which refers to the application of computati

Updated on: January 06,2024

AI in histopathology image analysis for cancer precision medicine

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainIn recent years, there have been rapid advancements in the field of computational pathology, which refers to the application of computati

Updated on:January 06,2024

Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

by Cara MurezBile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.Knowing the signs of these rare cancers may help with earlier detection.Gallbladd

Updated on: December 20,2023

Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

by Cara MurezBile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.Knowing the signs of these rare cancers may help with earlier detection.Gallbladd

Updated on:December 20,2023

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on: October 15,2023

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on:October 15,2023

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Updated on: December 22,2023

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Updated on:December 22,2023